Hui‐Ming Yu

1.2k total citations
42 papers, 911 citations indexed

About

Hui‐Ming Yu is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Hui‐Ming Yu has authored 42 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Physiology. Recurrent topics in Hui‐Ming Yu's work include Monoclonal and Polyclonal Antibodies Research (4 papers), RNA and protein synthesis mechanisms (4 papers) and Chemical Synthesis and Analysis (4 papers). Hui‐Ming Yu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), RNA and protein synthesis mechanisms (4 papers) and Chemical Synthesis and Analysis (4 papers). Hui‐Ming Yu collaborates with scholars based in Taiwan, China and United States. Hui‐Ming Yu's co-authors include Shui‐Tein Chen, Jim‐Min Fang, Yun‐Ru Chen, Kung‐Tsung Wang, Chung‐Yi Wu, Chi‐Huey Wong, Suree Phutrakul, Nuansri Rakariyatham, Michael A. Freitas and Shengjiang Tu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Hui‐Ming Yu

41 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui‐Ming Yu Taiwan	19	474	97	95	93	92	42	911
Henry H. Le United States	17	496 1.0×	56 0.6×	84 0.9×	61 0.7×	83 0.9×	38	918
Federico Iacovelli Italy	20	685 1.4×	49 0.5×	101 1.1×	79 0.8×	47 0.5×	61	1.2k
Wenyan Wang China	16	847 1.8×	64 0.7×	90 0.9×	156 1.7×	85 0.9×	58	1.3k
Luciano Pirone Italy	21	798 1.7×	48 0.5×	88 0.9×	65 0.7×	64 0.7×	70	1.2k
Liang Huang China	19	591 1.2×	134 1.4×	67 0.7×	87 0.9×	38 0.4×	48	958
Kun Xu China	21	918 1.9×	90 0.9×	93 1.0×	106 1.1×	41 0.4×	65	1.3k
Angela Ostuni Italy	18	390 0.8×	37 0.4×	67 0.7×	148 1.6×	67 0.7×	71	1.1k
Abhay H. Pande India	18	548 1.2×	55 0.6×	216 2.3×	130 1.4×	76 0.8×	81	1.1k
Akhmed Aslam Saudi Arabia	18	540 1.1×	83 0.9×	83 0.9×	36 0.4×	42 0.5×	38	916

Countries citing papers authored by Hui‐Ming Yu

Since Specialization

Citations

This map shows the geographic impact of Hui‐Ming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ming Yu more than expected).

Fields of papers citing papers by Hui‐Ming Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Ming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ming Yu. The network helps show where Hui‐Ming Yu may publish in the future.

Co-authorship network of co-authors of Hui‐Ming Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Ming Yu. A scholar is included among the top collaborators of Hui‐Ming Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Ming Yu. Hui‐Ming Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Chun‐Mei, et al.. (2025). Innovative cyclic peptide disrupts IL-17RB–MLK4 interaction for targeted pancreatic cancer therapy. Biomedicine & Pharmacotherapy. 184. 117892–117892.

Tu, Shuqin, et al.. (2024). The urine formed element instance segmentation based on YOLOv5n. Scientific Reports. 14(1). 28658–28658. 2 indexed citations

Hsieh, Chung-Fan, Jia-Rong Jheng, Yu‐Li Chen, et al.. (2020). Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors. Emerging Microbes & Infections. 9(1). 1194–1205. 39 indexed citations

Ding, Chao, et al.. (2018). MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma. Biomedicine & Pharmacotherapy. 110. 528–536. 23 indexed citations

Chang, Chi‐Fon, et al.. (2017). Alzheimer’s amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity. PLoS ONE. 12(3). e0174561–e0174561. 28 indexed citations

Kim, Hyeonji, Chung‐Yi Wu, Hui‐Ming Yu, Jen Sheen, & Horim Lee. (2017). Dual CLAVATA3 peptides in Arabidopsis shoot stem cell signaling. Journal of Plant Biology. 60(5). 506–512. 13 indexed citations

Wang, Sheng‐Hung, I‐Ju Chen, Han‐Chung Wu, et al.. (2016). Structure-based optimization of GRP78-binding peptides that enhances efficacy in cancer imaging and therapy. Biomaterials. 94. 31–44. 37 indexed citations

Yu, Hui‐Ming, Jiun‐Jie Shie, Ting-Jen Rachel Cheng, et al.. (2014). Chemical constituents of Plectranthus amboinicus and the synthetic analogs possessing anti-inflammatory activity. Bioorganic & Medicinal Chemistry. 22(5). 1766–1772. 50 indexed citations

Chen, Heng‐Li, Pei-Yi Su, Ya‐Shu Chang, et al.. (2013). Identification of a Novel Antimicrobial Peptide from Human Hepatitis B Virus Core Protein Arginine-Rich Domain (ARD). PLoS Pathogens. 9(6). e1003425–e1003425. 47 indexed citations

10.

Lin, Chien‐Jen, et al.. (2012). Manipulating mIgD-expressing B cells with anti-migis-δ monoclonal antibodies. Molecular Immunology. 53(3). 187–197. 1 indexed citations

11.

Chang, Yu‐Ling, Ying‐Chu Chen, Hui‐Ming Yu, et al.. (2011). Tagging saccharides for signal enhancement in mass spectrometric analysis. Journal of Mass Spectrometry. 46(3). 247–255. 22 indexed citations

12.

Yu, Hui‐Ming, et al.. (2011). Lipid rafts hinder binding of antibodies to the extracellular segment of the membrane-anchor peptide of mIgA. Molecular Immunology. 48(15-16). 1975–1982. 1 indexed citations

13.

Liu, Meng, Anna-Karin Sjögren, Christin Karlsson, et al.. (2010). Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer. Proceedings of the National Academy of Sciences. 107(14). 6471–6476. 86 indexed citations

14.

Chu, Chia‐Yu, et al.. (2010). Unique Epitopes on CεmX in IgE–B Cell Receptors Are Potentially Applicable for Targeting IgE-Committed B Cells. The Journal of Immunology. 184(4). 1748–1756. 38 indexed citations

15.

Wang, Shiyun, Ching‐Yao Su, Meng‐I Lin, et al.. (2009). HA-Pseudotyped Retroviral Vectors for Influenza Antagonist Screening. SLAS DISCOVERY. 14(3). 294–302. 12 indexed citations

16.

Tsai, Keng‐Chang, et al.. (2008). Factor Xa Active Site Substrate Specificity with Substrate Phage Display and Computational Molecular Modeling. Journal of Biological Chemistry. 283(18). 12343–12353. 23 indexed citations

17.

Tu, Shengjiang, Esther M. M. Bulloch, Lanhao Yang, et al.. (2007). Identification of Histone Demethylases in Saccharomyces cerevisiae. Journal of Biological Chemistry. 282(19). 14262–14271. 90 indexed citations

18.

Yu, Hui‐Ming, et al.. (2004). Capillary electrophoresis using immobilized whole cells with overexpressed endothelin receptor for specific ligand screening. Electrophoresis. 25(7-8). 1034–1041. 6 indexed citations

19.

Yu, Hui‐Ming, et al.. (1996). Protein Engineering of Venom Toxins by Synthetic Approach and NMR Dynamic Simulation: Status of Basic Amino Acid Residues in Waglerin I. Biochemical and Biophysical Research Communications. 227(1). 59–63. 6 indexed citations

20.

Chen, Shui‐Tein, et al.. (1993). Facile synthesis of a short peptide with a side-chain constrained structure. Journal of Chemical Research Synopses. 228–229. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact